Form 483

Amgen, Inc. Form 483, 2012-12-12

FDA issued a Form 483 to Amgen, Inc. on 2012-12-12 with 8 public-safe observations.

483· Form 483 issued8 observations

Amgen, Inc. · Thousand Oaks, United States · Issued December 12, 2012

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Dec 2012
21 CFR 314.80(b)

Failure to develop written procedures

Cited by Sonia R Peterson, Caryn M Mcnab, Maxyne T Lam

12 Dec 2012
21 CFR 314.80(c)

Failure by applicant to report ADE

Cited by Sonia R Peterson, Caryn M Mcnab, Maxyne T Lam

12 Dec 2012
21 CFR 314.80(c)(1)(i)

Late submission of 15-day report

Cited by Sonia R Peterson, Caryn M Mcnab, Maxyne T Lam

12 Dec 2012
21 CFR 314.80(e)

Failure to report post-marketing study ADEs

Cited by Sonia R Peterson, Caryn M Mcnab, Maxyne T Lam

12 Dec 2012
21 CFR 600.80(b)

Review of Adverse Experiences - SOPs

Cited by Sonia R Peterson, Caryn M Mcnab, Maxyne T Lam

Inspected site

AIAmgen, Inc.Thousand Oaks, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 314.80(b)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 314.80(e)Cited across public-safe Form 483 observations1x
21 CFR 600.80(b)Cited across public-safe Form 483 observations1x
21 CFR 600.80(c)Cited across public-safe Form 483 observations1x
21 CFR 600.80(c)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 600.80(c)(1)(ii)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere